Shares of ANGLE plc (LON:AGL – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 11.26 ($0.14) and traded as low as GBX 10.50 ($0.13). ANGLE shares last traded at GBX 11.22 ($0.14), with a volume of 865,932 shares trading hands.
Analysts Set New Price Targets
Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 70 ($0.85) price objective on shares of ANGLE in a report on Thursday, September 26th.
Read Our Latest Analysis on AGL
ANGLE Price Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Featured Articles
- Five stocks we like better than ANGLE
- ESG Stocks, What Investors Should Know
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- How to Short a Stock in 5 Easy Steps
- Oilfield Leader SLB: An AI Name You Need to Know
- Insider Trades May Not Tell You What You Think
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
